Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far
- 28 October 2003
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 6 (5) , 257-269
- https://doi.org/10.1016/j.drup.2003.08.003
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Candidemia in a Tertiary Care Cancer CenterMedicine, 2003
- Scopulariopsis brevicaulis, a Fungal Pathogen Resistant to Broad-Spectrum Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2003
- Refractory Aspergillus pneumonia in patients with acute leukemiaCancer, 2003
- The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In VitroAntimicrobial Agents and Chemotherapy, 2002
- Pharmacodynamics of Amphotericin B in a Neutropenic-Mouse Disseminated-Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2001
- Interactions between Triazoles and Amphotericin B against Cryptococcus neoformansAntimicrobial Agents and Chemotherapy, 2000
- Formulation of Compounds and Determination of Pharmacokinetic ParametersPublished by Elsevier ,1999
- Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitisAIDS, 1992
- Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholateAntimicrobial Agents and Chemotherapy, 1989
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979